Overall rank by patents
#45,497
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, active 2024–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H04L (TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION).
The verdict
Chain holds 5 US patents across 3 technology areas, rank #45,497 of 50,000 tracked assignees.
Chain Reaction Ltd. has been granted 5 US utility patents between 2024 and 2025, placing Chain Reaction Ltd. at rank #45,497 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 28.0 claims per patent with primary concentration in H04L (TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION). As a Foreign Corporation, Chain Reaction Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Chain sits between CG Oncology, Inc. (5 patents, rank #45,493) and Chang YOW Technologies International Co., Ltd. (5 patents, rank #45,501) - the closest US assignees by grant volume. The composite Innovation Score of 47.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2024 through 2025, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Chain Reaction Ltd.'s 28.0 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Chain Reaction Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CG ONCOLOGY, INC.
5 patents
CGTech
5 patents
CGeneTech (Suzhou, China) CO., Ltd.
5 patents
CHACHA SEARCH, INC.
5 patents
CHAMPION TRUST LLC
5 patents
CHAMPTEK INCORPORATED
5 patents
CHANDLERTEC INC.
5 patents
CHANG YOW TECHNOLOGIES INTERNATIONAL CO., LTD.
5 patents
CHAIN REACTION LTD.
5 patents
What this shows Chain holds 5 patents at rank #45,497, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #45,497 in granted patent volume.
Other assignees with the most granted patents in Chain's primary technology class.
Chain's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
47 Top 19% higher than 81% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2024 | 3 | 60.0% |
| 2025 | 2 | 40.0% |
Top 3 of 3 technology areas
Overall rank by patents
#45,497
Across all tracked assignees
47.3 out of 100
How to use this portfolio
Chain's 5 grants land it in the top 19% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.